Change - Announcement of Cessation::CESSATION OF CHIEF OPERATING OFFICER

Issuer & Securities

Issuer/ Manager
ASIAMEDIC LIMITED
Securities
ASIAMEDIC LIMITED - SG0505000059 - 505
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
06-Jan-2022 18:52:16
Status
New
Announcement Sub Title
CESSATION OF CHIEF OPERATING OFFICER
Announcement Reference
SG220106OTHR4BOV
Submitted By (Co./ Ind. Name)
Stanley Woo
Designation
Group Financial Controller
Description (Please provide a detailed description of the event in the box below)
Resignation of Dr Wong Kae Thong as Chief Operating Officer.

Sponsor statement:
This announcement has been reviewed by the Company's Sponsor, Xandar Capital Pte Ltd, in compliance with Rule 226 of the Catalist Rules. It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd) at 3 Shenton Way, #24-02 Shenton House, Singapore 068805. Telephone number: (65) 63194954.

Additional Details

Name Of Person
Dr Wong Kae Thong (Dr Wong)
Age
45
Is effective date of cessation known?
Yes
If yes, please provide the date
02/04/2022
Detailed Reason (s) for cessation
Dr Wong had tendered her resignation as Chief Operating Officer of the Company to pursue personal and professional interests.

The Board is currently in discussion with Dr Wong on the possibility of her taking on another role in the Group so that the Group can continue to tap on her expertise. While Board is in discussion with Dr Wong, the Company has commenced the search of a replacement for Dr Wong in her role as COO, and will provide further updates in due course.

The Company's Sponsor, Xandar Capital Pte Ltd, has interviewed Dr Wong and is satisfied that, other than the reason as disclosed above, there are no material reasons for her cessation.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
01/01/2020
Does the AC have a minimum of 3 members (taking into account this cessation)?
No
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
3
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Operating Officer
Role and responsibilities
Reporting to the Board of Directors, responsible for managing day-to-day matters such as business development, operations and corporate matters to achieve the Group's goals and objectives.


Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
Nil.
Present
Nil.